
Healthcare #healthcare executive with more than 30 years experience in operating and investing in companies. #VC Partner @EarlybirdVC
Hamburg
Joined March 2012
- Tweets77
- Following73
- Followers179
- Likes132
Thom Rasche retweeted
2022 was memorable! 🎢
We ran the numbers 📊 :
82 investments 💸
81 people on teams 👋
33 Earlybird's View articles ✍️
3 Unicorns🦄
2 new offices 📍
1 mission to support European startups! ❤️🔥
👀 Year in Review w/ highlights across the family of funds: bit.ly/3HZ6U5d
Thom Rasche retweeted
We’ve entered into a strategic alliance with @abbvie. iSTAR Medical will receive a $60M non-dilutive upfront payment and AbbVie will hold the exclusive right to acquire iSTAR Medical at their discretion.
More: bit.ly/3oiH5Ss
#MIGS #MINIject #Glaucoma
Thom Rasche retweeted
🧬 Got a strong background in STEM?
🔬 Keen to explore a Career Beyond the Bench?
🔎 See more & apply for our Earlybird Health Fellowship bit.ly/3Azk6Ke
#hiring #healthcare #investing #fellowship #EBVCteam
@raschethom @hampshireUK @ChrisMassner @NasrallahRabab
Thom Rasche retweeted
Don't miss out on 5️⃣ key insights by Earlybird Health's @ChrisMassner on how #psychedelics could revolutionize #mentalhealth #treatment & why #VCs are investing in its research.
👀 a new Medium article👉🏽 bit.ly/3bpSlt8
w/ @raschethom, @NasrallahRabab & @ElishevaMarcus
Thom Rasche retweeted
Passen #KI-Medizinprodukte, #AIA und #EUMDR zusammen? Noch nicht ganz. Regulierungen müssen harmonisiert und die MDR KI-tauglich gestaltet werden, so die Expert:innen der Innovation Hall. Die KI-Vorteile in der Medizin zeigten sie mit Praxisbeispielen auf. bvmed.de/T/2022-06-23/medtec…
Thom Rasche retweeted
✍️New article in a Digital Health series: Maresa of Earlybird Digital West dives into the state of European #DigitalHealth Investments.
She covers #VC activity & distribution across stages + countries. Discover her data-driven forecasts.
👀 👉🏽 bit.ly/3naKPVH
#EBVCblog
Thom Rasche retweeted
For anyone trying to get into the VC space, this article is a must read 👇🏾cc:@ElishevaMarcus
"How can I break into VC?” Here's a complete guide.💥
In a new article, discover:
✔️ 4 proven ways to break into #VC
✔️ Benchmarks to highlight your edge
✔️ How to nail the VC #intern interview
✔️ What a VC intern does & learns
✔️ Exclusive #HR tips
👀 bit.ly/39AqqGn
Thom Rasche retweeted
At the #DOC2022, Prof. Dr med. Marc Schargus will present a meta-analysis from the STAR-I, II, III, trials on patients with open-angle #glaucoma implanted with #MINIject.
More here: bit.ly/3zlkxHD
#MIGS
There is no doubt: #Digital #Health investing is interesting and ambitious at the same time. How does it differ from #MedTech #investing?
➡️ Find my answer in this @MedTechStrat #article by @DCassak: bit.ly/3Nkx7KN
Thom Rasche retweeted
🇨🇭@TechTourHQ Health 2022 is returning for a 13th edition to Lausanne, #Switzerland.
🤝 Build long-lasting relationships with international #investors & #entrepreneurs in the #HealthTech field.
🗓June 21-22: Meet @ChrisMassner from Earlybird Health!
👉🏽 bit.ly/3MO32CT
Thom Rasche retweeted
Did you catch us at #EGS2022? The iSTAR Medical team thoroughly enjoyed the @EGUS_org congress in Athens.
Find out more here: bit.ly/3FVmITr
#MIGS #Ophthalmology #MINIject
Thom Rasche retweeted
„Viele [Startups] lernen gerade, dass es weniger um die Technologie und mehr um die Einführung eines Produkts in einen hochregulierten Gesundheitsmarkt geht“, so Thom Rasche @EarlybirdVC im @handelsblatt unter: handelsblatt.com/inside/digi…
Thom Rasche retweeted
"Many [startups] are just learning that it's less about the technology & more about launching a #product into a highly regulated #healthcare market." - @raschethom Partner, Earlybird Health
👀 @NasrallahRabab @ChrisMassner @LionelCarnot @hampshireUK @rolfmathies @ElishevaMarcus
„Viele [Startups] lernen gerade, dass es weniger um die Technologie und mehr um die Einführung eines Produkts in einen hochregulierten Gesundheitsmarkt geht“, so Thom Rasche @EarlybirdVC im @handelsblatt unter: handelsblatt.com/inside/digi…
Thom Rasche retweeted
🔬 Earlybird Health welcomes 🇫🇷@ImcheckThx to the #EBVCgang!
ImCheck develops nextgen immunotherapeutic antibodies targeting gamma-delta T cells for treating solid & hematological #cancers, infectious & autoimmune #diseases.
👀 Series C 📰@FierceBiotech bit.ly/3zwrOEH
Thom Rasche retweeted
We presented a meta-analysis from 3 international clinical trials for #MINIject, the only commercially available supraciliary #MIGS device, at the 15th @EUGS_org Congress in Athens.
More here: bit.ly/3hbjn
#EGS2022
Thom Rasche retweeted
📣 Beyond the Bench Seminar by @MGPA & @harvardmed’s @MassGeneralNews is your #chance to discover #opportunities #beyondacademia.
Join #healthcare #investing experts incl @NasrallahRabab of Earlybird Health
📍Thurs, 9 June 11:30pm CET/ 5:30pm EDT
👉🏽 Zoom bit.ly/3MjFZja
Thom Rasche retweeted
Hear from these speakers & many more on the 29-30 June 2022, at the first annual Bits & Pretzels HealthTech Conference hosted at ICM Munich.🎉
85% of our tickets have already sold out so the time to buy yours is now!🎟️
Link: bitsandpretzels.com/healthte…
#bitshealth #bitsandpretzels
Thom Rasche retweeted
A @Jefferies survey explored impact of funding on R&D budgets:
How will they change in new funding environments? What's the mindset of experienced #biotech investors?
Join a call w/ Earlybird Health's @LionelCarnot to learn more!
📍Tue May 24 10am ET
👉🏽bit.ly/3Pv8r4i
Thom Rasche retweeted
“Oviva is one of the few #digitalcare delivery #startups operating in multiple European countries while being reimbursed by different (#healthcare) systems,”
Our Principal @ChrisMassner on Earlybird Health's @OvivaHealth listed in @BusinessInsider 📰
👀 bit.ly/3Mzzbig
Thom Rasche retweeted
Super excited to announce the closing of Earlybird Digital West Fund VII – fueling European startups to achieve even more!🔥🚀
We're committed to innovation made in #Europe and grateful to our portfolio, investors, collaborators, team & community.🦄🦄
🔗📰👇🏽@TechCrunch, @faznet

























